Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment–Elevated Myocardial Infarction

Author:

Vernon Stephen T.123ORCID,Kott Katharine A.123ORCID,Hansen Thomas123,Finemore Meghan12,Baumgart Karl W.4,Bhindi Ravinay23,Yang Jean56ORCID,Hansen Peter S.23,Nicholls Stephen J.7,Celermajer David S.89ORCID,Ward Michael R.23,van Nunen Sheryl A.210,Grieve Stuart M.51112,Figtree Gemma A.1253ORCID

Affiliation:

1. Cardiovascular Discovery Group, Kolling Institute of Medical Research (S.T.V., K.A.K., T.H., M.F., G.A.F.) University of Sydney, Australia.

2. Northern Clinical School, Faculty of Medicine and Health (S.T.V., K.A.K., T.H., M.F., R.B., P.S.H., M.R.W., S.A.v.N., G.A.F.) University of Sydney, Australia.

3. Department of Cardiology, Royal North Shore Hospital, Australia (S.T.V., K.A.K., T.H., R.B., P.S.H., M.R.W., G.A.F.).

4. Douglass Hanly Moir Pathology, Sydney, Australia (K.W.B.).

5. Charles Perkins Centre (J.Y., S.M.G., G.A.F.) University of Sydney, Australia.

6. School of Mathematics and Statistics (J.Y.) University of Sydney, Australia.

7. Monash Cardiovascular Research Centre, Victorian Heart Institute, Monash University, Australia (S.J.N.).

8. Sydney Medical School (D.S.C.) University of Sydney, Australia.

9. Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia (D.S.C.).

10. Northern Beaches Hospital, Sydney, Australia (S.A.v.N.).

11. Imaging and Phenotyping Laboratory, Charles Perkins Centre, Faculty of Medicine and Health (S.M.G.), University of Sydney, Australia.

12. Department of Radiology, Royal Prince Alfred Hospital, Sydney, Australia (S.M.G.).

Abstract

Background: Treating known risk factors for coronary artery disease (CAD) has substantially reduced CAD morbidity and mortality. However, a significant burden of CAD remains unexplained. Immunoglobulin E sensitization to mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal) was recently associated with CAD in a small observational study. We sought to confirm that α-Gal sensitization is associated with CAD burden, in particular noncalcified plaque. Additionally, we sort to assess whether that α-Gal sensitization is associated with ST-segment–elevated myocardial infarction (STEMI) Methods: We performed a cross-sectional analysis of participants enrolled in the BioHEART cohort study. We measured α-Gal specific-immunoglobulin E antibodies in serum of 1056 patients referred for CT coronary angiography for suspected CAD and 100 selected patients presenting with STEMI, enriched for patients without standard modifiable risk factors. CT coronary angiograms were assessed using coronary artery calcium scores and segmental plaque scores. Results: α-Gal sensitization was associated with presence of noncalcified plaque (odds ratio, 1.62 [95% CI, 1.04–2.53], P =0.03) and obstructive CAD (odds ratio, 2.05 [95% CI, 1.29-3.25], P =0.002), independent of age, sex, and traditional risk factors. The α-Gal sensitization rate was 12.8-fold higher in patients with STEMI compared with matched healthy controls and 2.2-fold higher in the patients with STEMI compared with matched stable CAD patients (17% versus 1.3%, P =0.01 and 20% versus 9%, P =0.03, respectively). Conclusions: α-Gal sensitization is independently associated with noncalcified plaque burden and obstructive CAD and occurs at higher frequency in patients with STEMI than those with stable or no CAD. These findings may have implications for individuals exposed to ticks, as well as public health policy. Registration: URL: https://www.anzctr.org.au ; Unique identifier: ACTRN12618001322224.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Vascular Cytokines and Atherosclerosis: Differential Serum Levels of TRAIL, IL-18, and OPG in Obstructive Coronary Artery Disease;Biomolecules;2024-09-04

2. Is Alpha-Gal an Emerging Allergen in Drug Allergy?;Current Treatment Options in Allergy;2024-08-09

3. Alpha-Gal Syndrome and Cardiac Surgery;Journal of Cardiothoracic and Vascular Anesthesia;2024-07

4. Intrinsic risk factors for alpha-gal syndrome in a case-control study, 2019 to 2020;Annals of Allergy, Asthma & Immunology;2024-06

5. Identifying patients at risk of anaphylaxis;World Allergy Organization Journal;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3